BSETrident Texofab LtdHighNeutral
Announced Wed, 13 Aug · 21:16 IST

Un-Audited Financial Results for the quarter ended on June 30, 2025 along with Limited Review Report.

Pat Growth 25pctResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Trident Texofab reported its Q1 FY26 (quarter ended June 30, 2025) results with revenue from operations at Rs 2,807.68 lakhs, up about 9% from Rs 2,571.21 lakhs in the same quarter last year. Total income rose to Rs 2,851.58 lakhs versus Rs 2,657.50 lakhs YoY. Profit after tax (PAT) jumped roughly 46% to Rs 101.59 lakhs from Rs 69.56 lakhs in Q1 FY25, driven by lower overall expenses relative to revenue. Basic EPS improved to Rs 0.72 from Rs 0.69. The statutory auditor (Shah Kailash & Associates LLP) issued a clean limited review report with no qualifications. The Board also appointed CS Mehul Amareliya of Amareliya & Associates as Secretarial Auditor for FY 2025-26 to 2029-30. The company operates in a single segment — manufacturing and trading of grey cloth.

Likely market impact

Strong PAT growth of around 46% on modest revenue growth signals improved margins and cost efficiency, which is positive for shareholders. QoQ profit doubled versus Q4 FY25 (Rs 51.05 lakhs), reinforcing the operational momentum. The clean audit report and routine secretarial auditor appointment are governance positives and should not materially affect the stock.